Hong‐Jeng Yu
Papers
1
Total Citations
6
H-Index
1
About
Hong-Jeng Yu is a leading urologic oncologist whose research centers on advancing surgical treatments for prostate cancer, particularly through minimally invasive techniques. His major contributions focus on refining patient selection for laparoscopic radical prostatectomy (LRP) in high-risk disease, demonstrating that surgery alone can be oncologically effective for carefully chosen men. In his most cited work, a 2013 study of 241 patients from an Asian tertiary referral center, Yu showed that LRP monotherapy achieves favorable outcomes in high-risk prostate cancer patients with only one D'Amico risk factor, challenging the prevailing reliance on multimodal therapy. This study, with 6 citations, provides critical evidence for personalizing aggressive surgical intervention. Beyond this, Yu’s broader research explores optimizing perioperative outcomes and long-term cancer control in Asian populations, where prostate cancer epidemiology differs from Western cohorts. His work has helped establish LRP as a viable, less invasive option for select high-risk patients, balancing oncologic efficacy with quality of life. Yu’s contributions are particularly valuable for surgeons and oncologists seeking to tailor treatment strategies, making him a respected voice in urologic oncology and a key figure in advancing laparoscopic techniques in Asia.
Research Focus
Key Achievements
Top Papers
- 1